 | • レポートコード：MRC2-11QY08250 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、150ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は核内受容体RORガンマのグローバル市場について調査・分析したレポートです。種類別（BBI-6000、GRC-39815アクション、研究開発進捗、GSK-2981278、IMU-366、INV-17、その他）市場規模、用途別（慢性閉塞性肺疾患、喘息、軸性脊椎関節炎、乳がん、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別核内受容体RORガンマの競争状況、市場シェア ・世界の核内受容体RORガンマ市場：種類別市場規模 2015年-2020年（BBI-6000、GRC-39815アクション、研究開発進捗、GSK-2981278、IMU-366、INV-17、その他） ・世界の核内受容体RORガンマ市場：種類別市場規模予測 2021年-2026年（BBI-6000、GRC-39815アクション、研究開発進捗、GSK-2981278、IMU-366、INV-17、その他） ・世界の核内受容体RORガンマ市場：用途別市場規模 2015年-2020年（慢性閉塞性肺疾患、喘息、軸性脊椎関節炎、乳がん、その他） ・世界の核内受容体RORガンマ市場：用途別市場規模予測 2021年-2026年（慢性閉塞性肺疾患、喘息、軸性脊椎関節炎、乳がん、その他） ・北米の核内受容体RORガンマ市場分析：米国、カナダ ・ヨーロッパの核内受容体RORガンマ市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの核内受容体RORガンマ市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の核内受容体RORガンマ市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの核内受容体RORガンマ市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Genfit SA、GlaxoSmithKline Plc、Aurigene Discovery Technologies、Beijing Hanmi Pharmaceutical、Biogen Inc、AbbVie Inc、Eurofins Advinus、Brickell Biotech Inc、Pfizer Inc、Phenex Pharmaceuticals AG、Reata Pharmaceuticals Inc、Bristol-Myers Squibb Company、Celgene Corp、Eli Lilly、Glenmark Pharmaceuticals、Lead Pharma Holding BV ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Nuclear Receptor ROR Gamma Market
The global Nuclear Receptor ROR Gamma market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Nuclear Receptor ROR Gamma Scope and Market Size
Nuclear Receptor ROR Gamma market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Nuclear Receptor ROR Gamma market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Nuclear Receptor ROR Gamma market is segmented into
BBI-6000
GRC-39815Action
R&D Progress
GSK-2981278
IMU-366
INV-17
Others
Segment by Application, the Nuclear Receptor ROR Gamma market is segmented into
Chronic Obstructive Pulmonary Disease
Asthma
Axial Spondyloarthritis
Breast Cancer
Others
Regional and Country-level Analysis
The Nuclear Receptor ROR Gamma market is analysed and market size information is provided by regions (countries).
The key regions covered in the Nuclear Receptor ROR Gamma market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Nuclear Receptor ROR Gamma Market Share Analysis
Nuclear Receptor ROR Gamma market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Nuclear Receptor ROR Gamma business, the date to enter into the Nuclear Receptor ROR Gamma market, Nuclear Receptor ROR Gamma product introduction, recent developments, etc.
The major vendors covered:
Genfit SA
GlaxoSmithKline Plc
Aurigene Discovery Technologies
Beijing Hanmi Pharmaceutical
Biogen Inc
AbbVie Inc
Eurofins Advinus
Brickell Biotech Inc
Pfizer Inc
Phenex Pharmaceuticals AG
Reata Pharmaceuticals Inc
Bristol-Myers Squibb Company
Celgene Corp
Eli Lilly
Glenmark Pharmaceuticals
Lead Pharma Holding BV
1 Study Coverage
1.1 Nuclear Receptor ROR Gamma Product Introduction
1.2 Market Segments
1.3 Key Nuclear Receptor ROR Gamma Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Nuclear Receptor ROR Gamma Market Size Growth Rate by Type
1.4.2 BBI-6000
1.4.3 GRC-39815Action
1.4.4 R&D Progress
1.4.5 GSK-2981278
1.4.6 IMU-366
1.4.7 INV-17
1.4.8 Others
1.5 Market by Application
1.5.1 Global Nuclear Receptor ROR Gamma Market Size Growth Rate by Application
1.5.2 Chronic Obstructive Pulmonary Disease
1.5.3 Asthma
1.5.4 Axial Spondyloarthritis
1.5.5 Breast Cancer
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Nuclear Receptor ROR Gamma Market Size, Estimates and Forecasts
2.1.1 Global Nuclear Receptor ROR Gamma Revenue 2015-2026
2.1.2 Global Nuclear Receptor ROR Gamma Sales 2015-2026
2.2 Global Nuclear Receptor ROR Gamma, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Nuclear Receptor ROR Gamma Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Nuclear Receptor ROR Gamma Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Nuclear Receptor ROR Gamma Competitor Landscape by Players
3.1 Nuclear Receptor ROR Gamma Sales by Manufacturers
3.1.1 Nuclear Receptor ROR Gamma Sales by Manufacturers (2015-2020)
3.1.2 Nuclear Receptor ROR Gamma Sales Market Share by Manufacturers (2015-2020)
3.2 Nuclear Receptor ROR Gamma Revenue by Manufacturers
3.2.1 Nuclear Receptor ROR Gamma Revenue by Manufacturers (2015-2020)
3.2.2 Nuclear Receptor ROR Gamma Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Nuclear Receptor ROR Gamma Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Nuclear Receptor ROR Gamma Revenue in 2019
3.2.5 Global Nuclear Receptor ROR Gamma Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Nuclear Receptor ROR Gamma Price by Manufacturers
3.4 Nuclear Receptor ROR Gamma Manufacturing Base Distribution, Product Types
3.4.1 Nuclear Receptor ROR Gamma Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Nuclear Receptor ROR Gamma Product Type
3.4.3 Date of International Manufacturers Enter into Nuclear Receptor ROR Gamma Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Nuclear Receptor ROR Gamma Market Size by Type (2015-2020)
4.1.1 Global Nuclear Receptor ROR Gamma Sales by Type (2015-2020)
4.1.2 Global Nuclear Receptor ROR Gamma Revenue by Type (2015-2020)
4.1.3 Nuclear Receptor ROR Gamma Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Nuclear Receptor ROR Gamma Market Size Forecast by Type (2021-2026)
4.2.1 Global Nuclear Receptor ROR Gamma Sales Forecast by Type (2021-2026)
4.2.2 Global Nuclear Receptor ROR Gamma Revenue Forecast by Type (2021-2026)
4.2.3 Nuclear Receptor ROR Gamma Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Nuclear Receptor ROR Gamma Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Nuclear Receptor ROR Gamma Market Size by Application (2015-2020)
5.1.1 Global Nuclear Receptor ROR Gamma Sales by Application (2015-2020)
5.1.2 Global Nuclear Receptor ROR Gamma Revenue by Application (2015-2020)
5.1.3 Nuclear Receptor ROR Gamma Price by Application (2015-2020)
5.2 Nuclear Receptor ROR Gamma Market Size Forecast by Application (2021-2026)
5.2.1 Global Nuclear Receptor ROR Gamma Sales Forecast by Application (2021-2026)
5.2.2 Global Nuclear Receptor ROR Gamma Revenue Forecast by Application (2021-2026)
5.2.3 Global Nuclear Receptor ROR Gamma Price Forecast by Application (2021-2026)
6 North America
6.1 North America Nuclear Receptor ROR Gamma by Country
6.1.1 North America Nuclear Receptor ROR Gamma Sales by Country
6.1.2 North America Nuclear Receptor ROR Gamma Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Nuclear Receptor ROR Gamma Market Facts & Figures by Type
6.3 North America Nuclear Receptor ROR Gamma Market Facts & Figures by Application
7 Europe
7.1 Europe Nuclear Receptor ROR Gamma by Country
7.1.1 Europe Nuclear Receptor ROR Gamma Sales by Country
7.1.2 Europe Nuclear Receptor ROR Gamma Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Nuclear Receptor ROR Gamma Market Facts & Figures by Type
7.3 Europe Nuclear Receptor ROR Gamma Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Nuclear Receptor ROR Gamma by Region
8.1.1 Asia Pacific Nuclear Receptor ROR Gamma Sales by Region
8.1.2 Asia Pacific Nuclear Receptor ROR Gamma Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Nuclear Receptor ROR Gamma Market Facts & Figures by Type
8.3 Asia Pacific Nuclear Receptor ROR Gamma Market Facts & Figures by Application
9 Latin America
9.1 Latin America Nuclear Receptor ROR Gamma by Country
9.1.1 Latin America Nuclear Receptor ROR Gamma Sales by Country
9.1.2 Latin America Nuclear Receptor ROR Gamma Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Nuclear Receptor ROR Gamma Market Facts & Figures by Type
9.3 Central & South America Nuclear Receptor ROR Gamma Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Nuclear Receptor ROR Gamma by Country
10.1.1 Middle East and Africa Nuclear Receptor ROR Gamma Sales by Country
10.1.2 Middle East and Africa Nuclear Receptor ROR Gamma Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Nuclear Receptor ROR Gamma Market Facts & Figures by Type
10.3 Middle East and Africa Nuclear Receptor ROR Gamma Market Facts & Figures by Application
11 Company Profiles
11.1 Genfit SA
11.1.1 Genfit SA Corporation Information
11.1.2 Genfit SA Description and Business Overview
11.1.3 Genfit SA Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Genfit SA Nuclear Receptor ROR Gamma Products Offered
11.1.5 Genfit SA Related Developments
11.2 GlaxoSmithKline Plc
11.2.1 GlaxoSmithKline Plc Corporation Information
11.2.2 GlaxoSmithKline Plc Description and Business Overview
11.2.3 GlaxoSmithKline Plc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Products Offered
11.2.5 GlaxoSmithKline Plc Related Developments
11.3 Aurigene Discovery Technologies
11.3.1 Aurigene Discovery Technologies Corporation Information
11.3.2 Aurigene Discovery Technologies Description and Business Overview
11.3.3 Aurigene Discovery Technologies Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Aurigene Discovery Technologies Nuclear Receptor ROR Gamma Products Offered
11.3.5 Aurigene Discovery Technologies Related Developments
11.4 Beijing Hanmi Pharmaceutical
11.4.1 Beijing Hanmi Pharmaceutical Corporation Information
11.4.2 Beijing Hanmi Pharmaceutical Description and Business Overview
11.4.3 Beijing Hanmi Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Beijing Hanmi Pharmaceutical Nuclear Receptor ROR Gamma Products Offered
11.4.5 Beijing Hanmi Pharmaceutical Related Developments
11.5 Biogen Inc
11.5.1 Biogen Inc Corporation Information
11.5.2 Biogen Inc Description and Business Overview
11.5.3 Biogen Inc Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Biogen Inc Nuclear Receptor ROR Gamma Products Offered
11.5.5 Biogen Inc Related Developments
11.6 AbbVie Inc
11.6.1 AbbVie Inc Corporation Information
11.6.2 AbbVie Inc Description and Business Overview
11.6.3 AbbVie Inc Sales, Revenue and Gross Margin (2015-2020)
11.6.4 AbbVie Inc Nuclear Receptor ROR Gamma Products Offered
11.6.5 AbbVie Inc Related Developments
11.7 Eurofins Advinus
11.7.1 Eurofins Advinus Corporation Information
11.7.2 Eurofins Advinus Description and Business Overview
11.7.3 Eurofins Advinus Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Eurofins Advinus Nuclear Receptor ROR Gamma Products Offered
11.7.5 Eurofins Advinus Related Developments
11.8 Brickell Biotech Inc
11.8.1 Brickell Biotech Inc Corporation Information
11.8.2 Brickell Biotech Inc Description and Business Overview
11.8.3 Brickell Biotech Inc Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Brickell Biotech Inc Nuclear Receptor ROR Gamma Products Offered
11.8.5 Brickell Biotech Inc Related Developments
11.9 Pfizer Inc
11.9.1 Pfizer Inc Corporation Information
11.9.2 Pfizer Inc Description and Business Overview
11.9.3 Pfizer Inc Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Pfizer Inc Nuclear Receptor ROR Gamma Products Offered
11.9.5 Pfizer Inc Related Developments
11.10 Phenex Pharmaceuticals AG
11.10.1 Phenex Pharmaceuticals AG Corporation Information
11.10.2 Phenex Pharmaceuticals AG Description and Business Overview
11.10.3 Phenex Pharmaceuticals AG Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Products Offered
11.10.5 Phenex Pharmaceuticals AG Related Developments
11.1 Genfit SA
11.1.1 Genfit SA Corporation Information
11.1.2 Genfit SA Description and Business Overview
11.1.3 Genfit SA Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Genfit SA Nuclear Receptor ROR Gamma Products Offered
11.1.5 Genfit SA Related Developments
11.12 Bristol-Myers Squibb Company
11.12.1 Bristol-Myers Squibb Company Corporation Information
11.12.2 Bristol-Myers Squibb Company Description and Business Overview
11.12.3 Bristol-Myers Squibb Company Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Bristol-Myers Squibb Company Products Offered
11.12.5 Bristol-Myers Squibb Company Related Developments
11.13 Celgene Corp
11.13.1 Celgene Corp Corporation Information
11.13.2 Celgene Corp Description and Business Overview
11.13.3 Celgene Corp Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Celgene Corp Products Offered
11.13.5 Celgene Corp Related Developments
11.14 Eli Lilly
11.14.1 Eli Lilly Corporation Information
11.14.2 Eli Lilly Description and Business Overview
11.14.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Eli Lilly Products Offered
11.14.5 Eli Lilly Related Developments
11.15 Glenmark Pharmaceuticals
11.15.1 Glenmark Pharmaceuticals Corporation Information
11.15.2 Glenmark Pharmaceuticals Description and Business Overview
11.15.3 Glenmark Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Glenmark Pharmaceuticals Products Offered
11.15.5 Glenmark Pharmaceuticals Related Developments
11.16 Lead Pharma Holding BV
11.16.1 Lead Pharma Holding BV Corporation Information
11.16.2 Lead Pharma Holding BV Description and Business Overview
11.16.3 Lead Pharma Holding BV Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Lead Pharma Holding BV Products Offered
11.16.5 Lead Pharma Holding BV Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Nuclear Receptor ROR Gamma Market Estimates and Projections by Region
12.1.1 Global Nuclear Receptor ROR Gamma Sales Forecast by Regions 2021-2026
12.1.2 Global Nuclear Receptor ROR Gamma Revenue Forecast by Regions 2021-2026
12.2 North America Nuclear Receptor ROR Gamma Market Size Forecast (2021-2026)
12.2.1 North America: Nuclear Receptor ROR Gamma Sales Forecast (2021-2026)
12.2.2 North America: Nuclear Receptor ROR Gamma Revenue Forecast (2021-2026)
12.2.3 North America: Nuclear Receptor ROR Gamma Market Size Forecast by Country (2021-2026)
12.3 Europe Nuclear Receptor ROR Gamma Market Size Forecast (2021-2026)
12.3.1 Europe: Nuclear Receptor ROR Gamma Sales Forecast (2021-2026)
12.3.2 Europe: Nuclear Receptor ROR Gamma Revenue Forecast (2021-2026)
12.3.3 Europe: Nuclear Receptor ROR Gamma Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Nuclear Receptor ROR Gamma Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Nuclear Receptor ROR Gamma Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Nuclear Receptor ROR Gamma Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Nuclear Receptor ROR Gamma Market Size Forecast by Region (2021-2026)
12.5 Latin America Nuclear Receptor ROR Gamma Market Size Forecast (2021-2026)
12.5.1 Latin America: Nuclear Receptor ROR Gamma Sales Forecast (2021-2026)
12.5.2 Latin America: Nuclear Receptor ROR Gamma Revenue Forecast (2021-2026)
12.5.3 Latin America: Nuclear Receptor ROR Gamma Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Nuclear Receptor ROR Gamma Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Nuclear Receptor ROR Gamma Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Nuclear Receptor ROR Gamma Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Nuclear Receptor ROR Gamma Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Nuclear Receptor ROR Gamma Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Nuclear Receptor ROR Gamma Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Nuclear Receptor ROR Gamma Market Segments
Table 2. Ranking of Global Top Nuclear Receptor ROR Gamma Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Nuclear Receptor ROR Gamma Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of BBI-6000
Table 5. Major Manufacturers of GRC-39815Action
Table 6. Major Manufacturers of R&D Progress
Table 7. Major Manufacturers of GSK-2981278
Table 8. Major Manufacturers of IMU-366
Table 9. Major Manufacturers of INV-17
Table 10. Major Manufacturers of Others
Table 11. Global Nuclear Receptor ROR Gamma Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 12. Global Nuclear Receptor ROR Gamma Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 13. Global Nuclear Receptor ROR Gamma Sales by Regions 2015-2020 (K Pcs)
Table 14. Global Nuclear Receptor ROR Gamma Sales Market Share by Regions (2015-2020)
Table 15. Global Nuclear Receptor ROR Gamma Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Nuclear Receptor ROR Gamma Sales by Manufacturers (2015-2020) (K Pcs)
Table 17. Global Nuclear Receptor ROR Gamma Sales Share by Manufacturers (2015-2020)
Table 18. Global Nuclear Receptor ROR Gamma Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Nuclear Receptor ROR Gamma by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nuclear Receptor ROR Gamma as of 2019)
Table 20. Nuclear Receptor ROR Gamma Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Nuclear Receptor ROR Gamma Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Nuclear Receptor ROR Gamma Price (2015-2020) (USD/Pcs)
Table 23. Nuclear Receptor ROR Gamma Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Nuclear Receptor ROR Gamma Product Type
Table 25. Date of International Manufacturers Enter into Nuclear Receptor ROR Gamma Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Nuclear Receptor ROR Gamma Sales by Type (2015-2020) (K Pcs)
Table 28. Global Nuclear Receptor ROR Gamma Sales Share by Type (2015-2020)
Table 29. Global Nuclear Receptor ROR Gamma Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Nuclear Receptor ROR Gamma Revenue Share by Type (2015-2020)
Table 31. Nuclear Receptor ROR Gamma Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 32. Global Nuclear Receptor ROR Gamma Sales by Application (2015-2020) (K Pcs)
Table 33. Global Nuclear Receptor ROR Gamma Sales Share by Application (2015-2020)
Table 34. North America Nuclear Receptor ROR Gamma Sales by Country (2015-2020) (K Pcs)
Table 35. North America Nuclear Receptor ROR Gamma Sales Market Share by Country (2015-2020)
Table 36. North America Nuclear Receptor ROR Gamma Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Nuclear Receptor ROR Gamma Revenue Market Share by Country (2015-2020)
Table 38. North America Nuclear Receptor ROR Gamma Sales by Type (2015-2020) (K Pcs)
Table 39. North America Nuclear Receptor ROR Gamma Sales Market Share by Type (2015-2020)
Table 40. North America Nuclear Receptor ROR Gamma Sales by Application (2015-2020) (K Pcs)
Table 41. North America Nuclear Receptor ROR Gamma Sales Market Share by Application (2015-2020)
Table 42. Europe Nuclear Receptor ROR Gamma Sales by Country (2015-2020) (K Pcs)
Table 43. Europe Nuclear Receptor ROR Gamma Sales Market Share by Country (2015-2020)
Table 44. Europe Nuclear Receptor ROR Gamma Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Nuclear Receptor ROR Gamma Revenue Market Share by Country (2015-2020)
Table 46. Europe Nuclear Receptor ROR Gamma Sales by Type (2015-2020) (K Pcs)
Table 47. Europe Nuclear Receptor ROR Gamma Sales Market Share by Type (2015-2020)
Table 48. Europe Nuclear Receptor ROR Gamma Sales by Application (2015-2020) (K Pcs)
Table 49. Europe Nuclear Receptor ROR Gamma Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Nuclear Receptor ROR Gamma Sales by Region (2015-2020) (K Pcs)
Table 51. Asia Pacific Nuclear Receptor ROR Gamma Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Nuclear Receptor ROR Gamma Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Nuclear Receptor ROR Gamma Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Nuclear Receptor ROR Gamma Sales by Type (2015-2020) (K Pcs)
Table 55. Asia Pacific Nuclear Receptor ROR Gamma Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Nuclear Receptor ROR Gamma Sales by Application (2015-2020) (K Pcs)
Table 57. Asia Pacific Nuclear Receptor ROR Gamma Sales Market Share by Application (2015-2020)
Table 58. Latin America Nuclear Receptor ROR Gamma Sales by Country (2015-2020) (K Pcs)
Table 59. Latin America Nuclear Receptor ROR Gamma Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Nuclear Receptor ROR Gamma Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Nuclear Receptor ROR Gamma Revenue Market Share by Country (2015-2020)
Table 62. Latin America Nuclear Receptor ROR Gamma Sales by Type (2015-2020) (K Pcs)
Table 63. Latin America Nuclear Receptor ROR Gamma Sales Market Share by Type (2015-2020)
Table 64. Latin America Nuclear Receptor ROR Gamma Sales by Application (2015-2020) (K Pcs)
Table 65. Latin America Nuclear Receptor ROR Gamma Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Nuclear Receptor ROR Gamma Sales by Country (2015-2020) (K Pcs)
Table 67. Middle East and Africa Nuclear Receptor ROR Gamma Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Nuclear Receptor ROR Gamma Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Nuclear Receptor ROR Gamma Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Nuclear Receptor ROR Gamma Sales by Type (2015-2020) (K Pcs)
Table 71. Middle East and Africa Nuclear Receptor ROR Gamma Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Nuclear Receptor ROR Gamma Sales by Application (2015-2020) (K Pcs)
Table 73. Middle East and Africa Nuclear Receptor ROR Gamma Sales Market Share by Application (2015-2020)
Table 74. Genfit SA Corporation Information
Table 75. Genfit SA Description and Major Businesses
Table 76. Genfit SA Nuclear Receptor ROR Gamma Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 77. Genfit SA Product
Table 78. Genfit SA Recent Development
Table 79. GlaxoSmithKline Plc Corporation Information
Table 80. GlaxoSmithKline Plc Description and Major Businesses
Table 81. GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 82. GlaxoSmithKline Plc Product
Table 83. GlaxoSmithKline Plc Recent Development
Table 84. Aurigene Discovery Technologies Corporation Information
Table 85. Aurigene Discovery Technologies Description and Major Businesses
Table 86. Aurigene Discovery Technologies Nuclear Receptor ROR Gamma Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 87. Aurigene Discovery Technologies Product
Table 88. Aurigene Discovery Technologies Recent Development
Table 89. Beijing Hanmi Pharmaceutical Corporation Information
Table 90. Beijing Hanmi Pharmaceutical Description and Major Businesses
Table 91. Beijing Hanmi Pharmaceutical Nuclear Receptor ROR Gamma Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 92. Beijing Hanmi Pharmaceutical Product
Table 93. Beijing Hanmi Pharmaceutical Recent Development
Table 94. Biogen Inc Corporation Information
Table 95. Biogen Inc Description and Major Businesses
Table 96. Biogen Inc Nuclear Receptor ROR Gamma Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 97. Biogen Inc Product
Table 98. Biogen Inc Recent Development
Table 99. AbbVie Inc Corporation Information
Table 100. AbbVie Inc Description and Major Businesses
Table 101. AbbVie Inc Nuclear Receptor ROR Gamma Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 102. AbbVie Inc Product
Table 103. AbbVie Inc Recent Development
Table 104. Eurofins Advinus Corporation Information
Table 105. Eurofins Advinus Description and Major Businesses
Table 106. Eurofins Advinus Nuclear Receptor ROR Gamma Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 107. Eurofins Advinus Product
Table 108. Eurofins Advinus Recent Development
Table 109. Brickell Biotech Inc Corporation Information
Table 110. Brickell Biotech Inc Description and Major Businesses
Table 111. Brickell Biotech Inc Nuclear Receptor ROR Gamma Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 112. Brickell Biotech Inc Product
Table 113. Brickell Biotech Inc Recent Development
Table 114. Pfizer Inc Corporation Information
Table 115. Pfizer Inc Description and Major Businesses
Table 116. Pfizer Inc Nuclear Receptor ROR Gamma Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 117. Pfizer Inc Product
Table 118. Pfizer Inc Recent Development
Table 119. Phenex Pharmaceuticals AG Corporation Information
Table 120. Phenex Pharmaceuticals AG Description and Major Businesses
Table 121. Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 122. Phenex Pharmaceuticals AG Product
Table 123. Phenex Pharmaceuticals AG Recent Development
Table 124. Reata Pharmaceuticals Inc Corporation Information
Table 125. Reata Pharmaceuticals Inc Description and Major Businesses
Table 126. Reata Pharmaceuticals Inc Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 127. Reata Pharmaceuticals Inc Product
Table 128. Reata Pharmaceuticals Inc Recent Development
Table 129. Bristol-Myers Squibb Company Corporation Information
Table 130. Bristol-Myers Squibb Company Description and Major Businesses
Table 131. Bristol-Myers Squibb Company Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 132. Bristol-Myers Squibb Company Product
Table 133. Bristol-Myers Squibb Company Recent Development
Table 134. Celgene Corp Corporation Information
Table 135. Celgene Corp Description and Major Businesses
Table 136. Celgene Corp Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 137. Celgene Corp Product
Table 138. Celgene Corp Recent Development
Table 139. Eli Lilly Corporation Information
Table 140. Eli Lilly Description and Major Businesses
Table 141. Eli Lilly Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 142. Eli Lilly Product
Table 143. Eli Lilly Recent Development
Table 144. Glenmark Pharmaceuticals Corporation Information
Table 145. Glenmark Pharmaceuticals Description and Major Businesses
Table 146. Glenmark Pharmaceuticals Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 147. Glenmark Pharmaceuticals Product
Table 148. Glenmark Pharmaceuticals Recent Development
Table 149. Lead Pharma Holding BV Corporation Information
Table 150. Lead Pharma Holding BV Description and Major Businesses
Table 151. Lead Pharma Holding BV Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 152. Lead Pharma Holding BV Product
Table 153. Lead Pharma Holding BV Recent Development
Table 154. Global Nuclear Receptor ROR Gamma Sales Forecast by Regions (2021-2026) (K Pcs)
Table 155. Global Nuclear Receptor ROR Gamma Sales Market Share Forecast by Regions (2021-2026)
Table 156. Global Nuclear Receptor ROR Gamma Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 157. Global Nuclear Receptor ROR Gamma Revenue Market Share Forecast by Regions (2021-2026)
Table 158. North America: Nuclear Receptor ROR Gamma Sales Forecast by Country (2021-2026) (K Pcs)
Table 159. North America: Nuclear Receptor ROR Gamma Revenue Forecast by Country (2021-2026) (US$ Million)
Table 160. Europe: Nuclear Receptor ROR Gamma Sales Forecast by Country (2021-2026) (K Pcs)
Table 161. Europe: Nuclear Receptor ROR Gamma Revenue Forecast by Country (2021-2026) (US$ Million)
Table 162. Asia Pacific: Nuclear Receptor ROR Gamma Sales Forecast by Region (2021-2026) (K Pcs)
Table 163. Asia Pacific: Nuclear Receptor ROR Gamma Revenue Forecast by Region (2021-2026) (US$ Million)
Table 164. Latin America: Nuclear Receptor ROR Gamma Sales Forecast by Country (2021-2026) (K Pcs)
Table 165. Latin America: Nuclear Receptor ROR Gamma Revenue Forecast by Country (2021-2026) (US$ Million)
Table 166. Middle East and Africa: Nuclear Receptor ROR Gamma Sales Forecast by Country (2021-2026) (K Pcs)
Table 167. Middle East and Africa: Nuclear Receptor ROR Gamma Revenue Forecast by Country (2021-2026) (US$ Million)
Table 168. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 169. Key Challenges
Table 170. Market Risks
Table 171. Main Points Interviewed from Key Nuclear Receptor ROR Gamma Players
Table 172. Nuclear Receptor ROR Gamma Customers List
Table 173. Nuclear Receptor ROR Gamma Distributors List
Table 174. Research Programs/Design for This Report
Table 175. Key Data Information from Secondary Sources
Table 176. Key Data Information from Primary Sources
List of Figures
Figure 1. Nuclear Receptor ROR Gamma Product Picture
Figure 2. Global Nuclear Receptor ROR Gamma Sales Market Share by Type in 2020 & 2026
Figure 3. BBI-6000 Product Picture
Figure 4. GRC-39815Action Product Picture
Figure 5. R&D Progress Product Picture
Figure 6. GSK-2981278 Product Picture
Figure 7. IMU-366 Product Picture
Figure 8. INV-17 Product Picture
Figure 9. Others Product Picture
Figure 10. Global Nuclear Receptor ROR Gamma Sales Market Share by Application in 2020 & 2026
Figure 11. Chronic Obstructive Pulmonary Disease
Figure 12. Asthma
Figure 13. Axial Spondyloarthritis
Figure 14. Breast Cancer
Figure 15. Others
Figure 16. Nuclear Receptor ROR Gamma Report Years Considered
Figure 17. Global Nuclear Receptor ROR Gamma Market Size 2015-2026 (US$ Million)
Figure 18. Global Nuclear Receptor ROR Gamma Sales 2015-2026 (K Pcs)
Figure 19. Global Nuclear Receptor ROR Gamma Market Size Market Share by Region: 2020 Versus 2026
Figure 20. Global Nuclear Receptor ROR Gamma Sales Market Share by Region (2015-2020)
Figure 21. Global Nuclear Receptor ROR Gamma Sales Market Share by Region in 2019
Figure 22. Global Nuclear Receptor ROR Gamma Revenue Market Share by Region (2015-2020)
Figure 23. Global Nuclear Receptor ROR Gamma Revenue Market Share by Region in 2019
Figure 24. Global Nuclear Receptor ROR Gamma Sales Share by Manufacturer in 2019
Figure 25. The Top 10 and 5 Players Market Share by Nuclear Receptor ROR Gamma Revenue in 2019
Figure 26. Nuclear Receptor ROR Gamma Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Nuclear Receptor ROR Gamma Sales Market Share by Type (2015-2020)
Figure 28. Global Nuclear Receptor ROR Gamma Sales Market Share by Type in 2019
Figure 29. Global Nuclear Receptor ROR Gamma Revenue Market Share by Type (2015-2020)
Figure 30. Global Nuclear Receptor ROR Gamma Revenue Market Share by Type in 2019
Figure 31. Global Nuclear Receptor ROR Gamma Market Share by Price Range (2015-2020)
Figure 32. Global Nuclear Receptor ROR Gamma Sales Market Share by Application (2015-2020)
Figure 33. Global Nuclear Receptor ROR Gamma Sales Market Share by Application in 2019
Figure 34. Global Nuclear Receptor ROR Gamma Revenue Market Share by Application (2015-2020)
Figure 35. Global Nuclear Receptor ROR Gamma Revenue Market Share by Application in 2019
Figure 36. North America Nuclear Receptor ROR Gamma Sales Growth Rate 2015-2020 (K Pcs)
Figure 37. North America Nuclear Receptor ROR Gamma Revenue Growth Rate 2015-2020 (US$ Million)
Figure 38. North America Nuclear Receptor ROR Gamma Sales Market Share by Country in 2019
Figure 39. North America Nuclear Receptor ROR Gamma Revenue Market Share by Country in 2019
Figure 40. U.S. Nuclear Receptor ROR Gamma Sales Growth Rate (2015-2020) (K Pcs)
Figure 41. U.S. Nuclear Receptor ROR Gamma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Canada Nuclear Receptor ROR Gamma Sales Growth Rate (2015-2020) (K Pcs)
Figure 43. Canada Nuclear Receptor ROR Gamma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. North America Nuclear Receptor ROR Gamma Market Share by Type in 2019
Figure 45. North America Nuclear Receptor ROR Gamma Market Share by Application in 2019
Figure 46. Europe Nuclear Receptor ROR Gamma Sales Growth Rate 2015-2020 (K Pcs)
Figure 47. Europe Nuclear Receptor ROR Gamma Revenue Growth Rate 2015-2020 (US$ Million)
Figure 48. Europe Nuclear Receptor ROR Gamma Sales Market Share by Country in 2019
Figure 49. Europe Nuclear Receptor ROR Gamma Revenue Market Share by Country in 2019
Figure 50. Germany Nuclear Receptor ROR Gamma Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. Germany Nuclear Receptor ROR Gamma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. France Nuclear Receptor ROR Gamma Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. France Nuclear Receptor ROR Gamma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. U.K. Nuclear Receptor ROR Gamma Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. U.K. Nuclear Receptor ROR Gamma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Italy Nuclear Receptor ROR Gamma Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. Italy Nuclear Receptor ROR Gamma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Russia Nuclear Receptor ROR Gamma Sales Growth Rate (2015-2020) (K Pcs)
Figure 59. Russia Nuclear Receptor ROR Gamma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Europe Nuclear Receptor ROR Gamma Market Share by Type in 2019
Figure 61. Europe Nuclear Receptor ROR Gamma Market Share by Application in 2019
Figure 62. Asia Pacific Nuclear Receptor ROR Gamma Sales Growth Rate 2015-2020 (K Pcs)
Figure 63. Asia Pacific Nuclear Receptor ROR Gamma Revenue Growth Rate 2015-2020 (US$ Million)
Figure 64. Asia Pacific Nuclear Receptor ROR Gamma Sales Market Share by Region in 2019
Figure 65. Asia Pacific Nuclear Receptor ROR Gamma Revenue Market Share by Region in 2019
Figure 66. China Nuclear Receptor ROR Gamma Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. China Nuclear Receptor ROR Gamma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Japan Nuclear Receptor ROR Gamma Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. Japan Nuclear Receptor ROR Gamma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. South Korea Nuclear Receptor ROR Gamma Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. South Korea Nuclear Receptor ROR Gamma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. India Nuclear Receptor ROR Gamma Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. India Nuclear Receptor ROR Gamma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Australia Nuclear Receptor ROR Gamma Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Australia Nuclear Receptor ROR Gamma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Taiwan Nuclear Receptor ROR Gamma Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Taiwan Nuclear Receptor ROR Gamma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Indonesia Nuclear Receptor ROR Gamma Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Indonesia Nuclear Receptor ROR Gamma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Thailand Nuclear Receptor ROR Gamma Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Thailand Nuclear Receptor ROR Gamma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Malaysia Nuclear Receptor ROR Gamma Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Malaysia Nuclear Receptor ROR Gamma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Philippines Nuclear Receptor ROR Gamma Sales Growth Rate (2015-2020) (K Pcs)
Figure 85. Philippines Nuclear Receptor ROR Gamma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Vietnam Nuclear Receptor ROR Gamma Sales Growth Rate (2015-2020) (K Pcs)
Figure 87. Vietnam Nuclear Receptor ROR Gamma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Asia Pacific Nuclear Receptor ROR Gamma Market Share by Type in 2019
Figure 89. Asia Pacific Nuclear Receptor ROR Gamma Market Share by Application in 2019
Figure 90. Latin America Nuclear Receptor ROR Gamma Sales Growth Rate 2015-2020 (K Pcs)
Figure 91. Latin America Nuclear Receptor ROR Gamma Revenue Growth Rate 2015-2020 (US$ Million)
Figure 92. Latin America Nuclear Receptor ROR Gamma Sales Market Share by Country in 2019
Figure 93. Latin America Nuclear Receptor ROR Gamma Revenue Market Share by Country in 2019
Figure 94. Mexico Nuclear Receptor ROR Gamma Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Mexico Nuclear Receptor ROR Gamma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Brazil Nuclear Receptor ROR Gamma Sales Growth Rate (2015-2020) (K Pcs)
Figure 97. Brazil Nuclear Receptor ROR Gamma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Argentina Nuclear Receptor ROR Gamma Sales Growth Rate (2015-2020) (K Pcs)
Figure 99. Argentina Nuclear Receptor ROR Gamma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Latin America Nuclear Receptor ROR Gamma Market Share by Type in 2019
Figure 101. Latin America Nuclear Receptor ROR Gamma Market Share by Application in 2019
Figure 102. Middle East and Africa Nuclear Receptor ROR Gamma Sales Growth Rate 2015-2020 (K Pcs)
Figure 103. Middle East and Africa Nuclear Receptor ROR Gamma Revenue Growth Rate 2015-2020 (US$ Million)
Figure 104. Middle East and Africa Nuclear Receptor ROR Gamma Sales Market Share by Country in 2019
Figure 105. Middle East and Africa Nuclear Receptor ROR Gamma Revenue Market Share by Country in 2019
Figure 106. Turkey Nuclear Receptor ROR Gamma Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. Turkey Nuclear Receptor ROR Gamma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Saudi Arabia Nuclear Receptor ROR Gamma Sales Growth Rate (2015-2020) (K Pcs)
Figure 109. Saudi Arabia Nuclear Receptor ROR Gamma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. U.A.E Nuclear Receptor ROR Gamma Sales Growth Rate (2015-2020) (K Pcs)
Figure 111. U.A.E Nuclear Receptor ROR Gamma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 112. Middle East and Africa Nuclear Receptor ROR Gamma Market Share by Type in 2019
Figure 113. Middle East and Africa Nuclear Receptor ROR Gamma Market Share by Application in 2019
Figure 114. North America Nuclear Receptor ROR Gamma Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. North America Nuclear Receptor ROR Gamma Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Europe Nuclear Receptor ROR Gamma Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Europe Nuclear Receptor ROR Gamma Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Asia Pacific Nuclear Receptor ROR Gamma Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Asia Pacific Nuclear Receptor ROR Gamma Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Latin America Nuclear Receptor ROR Gamma Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 121. Latin America Nuclear Receptor ROR Gamma Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Middle East and Africa Nuclear Receptor ROR Gamma Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 123. Middle East and Africa Nuclear Receptor ROR Gamma Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Porter's Five Forces Analysis
Figure 125. Channels of Distribution
Figure 126. Distributors Profiles
Figure 127. Bottom-up and Top-down Approaches for This Report
Figure 128. Data Triangulation
Figure 129. Key Executives Interviewed
ガンマアミノ酪酸受容体サブユニットガンマ2の世界市場（～2026年） Market Analysis and Insights: Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market The global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Gamma-Aminobutyri…- 低親和性免疫グロブリンガンマFc領域受容体II-bの世界市場（～2026年） Market Analysis and Insights: Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market The global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global…
- レチノイン酸受容体ガンマの世界市場（～2026年） Market Analysis and Insights: Global Retinoic Acid Receptor Gamma Market The global Retinoic Acid Receptor Gamma market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Retinoic Acid Receptor Gamma Scope and Market Size Retino…
- タンパク質グルタミンガンマグルタミルトランスフェラーゼ2の世界市場（～2026年） Market Analysis and Insights: Global Protein Glutamine Gamma Glutamyltransferase 2 Market The global Protein Glutamine Gamma Glutamyltransferase 2 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Protein Glutamine Gamma…
- RACガンマセリン/スレオニンプロテインキナーゼの世界市場（～2026年） Market Analysis and Insights: Global RAC Gamma Serine/Threonine Protein Kinase Market The global RAC Gamma Serine/Threonine Protein Kinase market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global RAC Gamma Serine/Threonine Prot…